Long-Term Physical Stability of PVP-and PVPVA-Amorphous Solid Dispersions

被引:130
作者
Lehmkemper, Kristin [1 ,2 ]
Kyeremateng, Samuel O. [1 ]
Heinzerling, Oliver [1 ]
Degenhardt, Matthias [1 ]
Sadowski, Gabriele [2 ]
机构
[1] AbbVie Deutschland GmbH & Co KG, Global Pharmaceut R&D, Knollstr, D-67061 Ludwigshafen, Germany
[2] TU Dortmund, Dept Biochem & Chem Engn, Lab Thermodynam, Emil Figge Str 70, D-44227 Dortmund, Germany
关键词
amorphous solid dispersion; phase behavior; long-term stability studies; relative humidity; thermodynamic model; Flory-Huggins; PC-SAFT; acetaminophen; naproxen; polymer; PERTURBED-CHAIN SAFT; HYDROGEN-BONDING INTERACTIONS; GLASS-TRANSITION TEMPERATURE; DRUG-POLYMER MISCIBILITY; PHASE-BEHAVIOR; MOLECULAR MOBILITY; SOLUBILITY ADVANTAGE; PHARMACEUTICAL SOLIDS; CRYSTALLINE DRUGS; STATE;
D O I
10.1021/acs.molpharmaceut.6b00763
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The preparation of amorphous solid dispersion (ASD) formulations is a promising strategy to improve the bioavailability of an active pharmaceutical ingredient (API). By dissolving the API in a polymer it is stabilized in its amorphous form, which usually shows higher water solubility than its crystalline counterpart. To prevent recrystallization, the long-term physical stability of ASD formulations is of big interest. In this work, the solubility of the APIs acetaminophen and naproxen in the excipient polymers poly(vinylpyrrolidone) (PVP K25) and poly(vinylpyrrolidone-co-vinyl acetate) (PVPVA64) was calculated with three models: the Perturbed-Chain Statistical Associating Fluid Theory (PC-SAFT), the Flory-Huggins model (FH), and an empirical model (Kyeremateng et al., J. Pharm. Sci, 2014, RA 2847-2858). PC-SAFT and FH were further used to predict the influence of relative humidity (RH) on the API solubility in the polymers. The Gordon Taylor equation was applied to model the glass-transition temperature of dry ASD and at humid conditions. The Calculations were validated by 18 months long stability studies at standardized storage conditions,. 25 degrees C/0% RH, 25 degrees C/60% RH, and 40 degrees C/75% RH. The results of the three modeling approaches for the API solubility in polymers agreed with the experimental solubility data, which are only accessible at high temperatures in dry polymers. However, at room temperature FH resulted in a lower solubility of the APIs in the dry polymers than PC-SAFT and the empirical model. The impact of RH on the solubility of acetaminophen was predicted to be small, but naproxen solubility in the polymers was predicted to-decrease with increasing RH with both, PC-SAFT and FH. At 25 degrees C/60% RH and 40 degrees C/75% RH, PC-SAFT is in agreement with all results of the long-term stability studies, while FH underestimates the acetaminophen solubility in PVP K25 and PVPVA64.
引用
收藏
页码:157 / 171
页数:15
相关论文
共 50 条
  • [41] Stability Challenges of Amorphous Solid Dispersions of Drugs: A Critical Review on Mechanistic Aspects
    Pisay, Muralidhar
    Padya, Bharath Singh
    Mutalik, Srinivas
    Koteshwara, Kunnatur B.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2024, 41 (03): : 45 - 94
  • [42] Exploring the effect of protein secondary structure on the solid state and physical stability of protein-based amorphous solid dispersions
    Zhuo, Xuezhi
    Ochner, Julia
    Leng, Donglei
    Fodera, Vito
    Lobmann, Korbinian
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 198
  • [43] Amorphous Solid Dispersions of Sulfonamide/Soluplus® and Sulfonamide/PVP Prepared by Ball Milling
    Caron, Vincent
    Hu, Yun
    Tajber, Lidia
    Erxleben, Andrea
    Corrigan, Owen I.
    McArdle, Patrick
    Healy, Anne Marie
    AAPS PHARMSCITECH, 2013, 14 (01): : 464 - 474
  • [44] Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions
    LaFountaine, Justin S.
    Prasad, Leena Kumari
    Brough, Chris
    Miller, Dave A.
    McGinity, James W.
    Williams, Robert O., III
    AAPS PHARMSCITECH, 2016, 17 (01): : 120 - 132
  • [45] Solution Behavior of PVP-VA and HPMC-AS-Based Amorphous Solid Dispersions and Their Bioavailability Implications
    Qian, Feng
    Wang, Jennifer
    Hartley, Ruiling
    Tao, Jing
    Haddadin, Raja
    Mathias, Neil
    Hussain, Munir
    PHARMACEUTICAL RESEARCH, 2012, 29 (10) : 2766 - 2776
  • [46] Understanding the effect of plasticizers in fi lm coat materials on the physical stability of amorphous solid dispersions
    Chatterjee, Kaustav
    Punia, Ashish
    Confer, Alex M.
    Lamm, Matthew S.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 114 (01) : 468 - 476
  • [47] Crystallization Risk Assessment of Amorphous Solid Dispersions by Physical Shelf-Life Modeling: A Practical Approach
    Liu, Bo
    Theil, Frank
    Lehmkemper, Kristin
    Gessner, David
    Li, Yanxia
    van Lishaut, Holger
    MOLECULAR PHARMACEUTICS, 2021, 18 (06) : 2428 - 2437
  • [48] The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions
    DeBoyace, Kevin
    Wildfong, Peter L. D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (01) : 57 - 74
  • [49] Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques
    Zhang, Zhaoyang
    Dong, Luning
    Guo, Jueshuo
    Li, Li
    Tian, Bin
    Zhao, Qipeng
    Yang, Jianhong
    EXPERT OPINION ON DRUG DELIVERY, 2021, 18 (02) : 249 - 264
  • [50] Physical stability of L-ascorbic acid amorphous solid dispersions in different polymers: A study of polymer crystallization inhibitor properties
    Christina, Belinda
    Taylor, Lynne S.
    Mauer, Lisa J.
    FOOD RESEARCH INTERNATIONAL, 2015, 76 : 867 - 877